01
July
2025
Share on networks
New Smith+Nephew Barcelona Campus consolidates Catalonia as European benchmark in healthcare innovation
The British multinational corporation has inaugurated a centre in Esplugues de Llobregat to host surgical training on cutting-edge technology

Catalonia is consolidating its place as a strategic hub for healthcare innovation with the inauguration of the new hub of excellence of the British multinational corporation Smith+Nephew. The new facilities, located in Esplugues de Llobregat, are called ‘Campus Barcelona S+N’ and have 2,000 square metres of space for roughly a hundred professionals.
The company has invested €5 million in the Campus, which includes a latest-generation skills centre equipped with surgical robots, augmented- and virtual-reality simulators and surgical navigation technologies. It also features a showroom, hundred-seat auditorium and sound stage to create scientific content for global use.
At the Campus presentation, Smith+Nephew representatives highlighted that the company isn’t just investing in a facility, it is making a firm commitment to local talent, scientific development and continuing to make Catalonia a benchmark in biomedicine in Europe and the world. New technologies will allow for more precise, less invasive surgery in the future, with a faster recovery time.
The British multinational corporation will hire new professionals and is looking for highly qualified candidates, mainly in bioengineering, biology, artificial intelligence applied to health, IT and digital surgery, among others.
According to data from ACCIÓ, between 2020 and 2024 Catalonia secured nearly a third of all British investment projects in Spain, specifically 63 projects with €2.209 billion in capital invested and 6,000 jobs created. There are currently 955 British subsidiaries in Catalonia.
Related news

El Prat airport expansion gets green light: €3.2 billion to be invested to reach 70 million passengers

Barcelona among top five start-up hubs in European Union for second year in a row

Consolidation of life sciences in Catalonia as driving force for innovation and growth: €220 million invested and 8.7% of GDP

Subscribe our Newsletter
Subscribe
Follow us on social